Skip to main content
. 2023 Jun 30;32(2):59–67. doi: 10.5114/ppn.2023.129048

Table 4.

Percentage of modified and unmodified therapies depending on the applied drug

Interferon β-1b Interferon β-1a Glatiramer acetate Dimethyl fumarate Peginterferon β-1a Teriflunomide
Modified therapies (switching or discontinuation) [%] 97 100 76 26 66 0
Unmodified therapies [%] 3 0 24 74 34 100